Wintergreen Acquisition Corp. Amends S-4 for KIKA Merger, Secures $5M-$10M Backstop to Ensure Closing
WTG is trading near its 52-week low of $9.74 (7.3% above the low) on elevated volume (31× avg).
Summary
Wintergreen Acquisition Corp. filed an amended S-4 for its $80 million merger with KIKA Technology Inc., including a new $5M-$10M financing commitment to ensure the deal closes and to address potential post-merger liquidity issues.
Key Events · M&A and Partnerships · WTG
-
Merger Update
Finalizes terms for the $80 million merger with KIKA Technology Inc., which will become KIKA Inc. This follows the initial S-4 filing on 2026-04-17.
-
Significant Dilution
Public shareholders face substantial dilution, with ownership decreasing from 80% pre-merger to between 0% and 34.8% post-merger, depending on redemption levels.
-
Committed Financing Secured
KIKA has secured commitments from prospective investors to purchase $5 million to $10 million in shares upon completion of the business combination. This is intended to mitigate the risk of failing the $5,000,001 minimum cash condition and address potential post-merger working capital deficiencies, especially under high redemption scenarios.
-
Governance Changes
The post-merger board will include two directors from Wintergreen (Xiangxiang Wei and Ru Ding), ensuring continuity in financial reporting and corporate governance.
Analysis · WTG · Life Sciences
This S-4/A provides updated details for Wintergreen's proposed $80 million merger with KIKA Technology Inc., which will be renamed KIKA Inc. The filing reveals a new commitment from prospective investors to purchase $5 million to $10 million in shares, directly addressing the critical $5,000,001 minimum cash condition and mitigating the risk of a severe working capital deficiency under high redemption scenarios. This significantly de-risks the transaction's closing and post-merger liquidity, which is crucial given both companies' going concern warnings. While the merger entails substantial dilution for existing public shareholders and highlights the sponsor's significant promote, the secured financing is a material positive development for deal certainty.
How filings like this one have moved
In the 30 days to Oct 22, 2026, 36.9% of the 1029 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.77%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, WTG was trading at $10.45 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $76.3M. The 52-week trading range was $9.74 to $10.46. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.